Cuu Long Pharmaceutical JSC (HOSE: DCL)

Market Cap	1.88T
Revenue (ttm)	1.21T
Net Income (ttm)	63.65B
Shares Out	73.04M
EPS (ttm)	871.45
PE Ratio	29.55
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	71,400
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	21,700 - 32,000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2024

About DCL

Cuu Long Pharmaceutical Joint Stock Company manufactures and distributes pharmaceutical products primarily in Vietnam. The company offers analgesic, anti-biotic, anti-histamine, anti-inflammatory, anti-virus, cardiovascular, corticosteroid, cough, dermatology, gastrointestinal, musculoskeletal, and vitamin medicines, as well as capsules and medical equipment. It provides its products under various brands to hospitals through its distribution network, including branches and distributors. The company was founded in 1976 and is headquartered in Vi...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 930
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DCL

Financial Performance

In 2023, DCL's revenue was 1.14 trillion, an increase of 12.63% compared to the previous year's 1.02 trillion. Earnings were 61.72 billion, a decrease of -43.19%.